| Current Price | $3.68 | Mkt Cap | $277.73M |
|---|---|---|---|
| Open | $3.67 | P/E Ratio | 0.00 |
| Prev. Close | $3.70 | Div. (Yield) | N/A (N/A) |
| Daily Range | $3.66 - $3.72 | Volume | 63,753 |
| 52-Wk Range | $2.85 - $4.47 | Avg. Daily Vol. | 0 |
News & Discussion Boards
- Immunomedics Inc. Stock Upgraded (IMMU) 2/10/2012 6:00:55 AM -
- Immunomedics Announces Second Quarter Fiscal 2012 Results and Clinical Program Developments 2/8/2012 8:46:49 AM -
- Small Biotech Companies With Big, Promising Pipelines 1/31/2012 3:51:15 PM -
- Immunomedics Awarded Broad Patent for Anti-CD20 and Anti-CD22 Combination Therapy 1/31/2012 8:46:10 AM -
- UCB-Astellas Collaborate - Analyst Blog 2/7/2012 5:32:01 PM
- CNS Cure Priority for UCB & Partner - Analyst Blog 1/13/2012 9:00:01 AM
- UCB-Immunomedics Restructure Deal - Analyst Blog 1/5/2012 5:50:01 PM
- Biotech Post-Holiday Regifting 12/28/2011 3:41:59 PM
| Subject | Recs | Author | Date |
|---|



